These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 30710416)

  • 1. Improvement of Aglycone π-Stacking Yields Nanomolar to Sub-nanomolar FimH Antagonists.
    Schönemann W; Cramer J; Mühlethaler T; Fiege B; Silbermann M; Rabbani S; Dätwyler P; Zihlmann P; Jakob RP; Sager CP; Smieško M; Schwardt O; Maier T; Ernst B
    ChemMedChem; 2019 Apr; 14(7):749-757. PubMed ID: 30710416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational switch of the bacterial adhesin FimH in the absence of the regulatory domain: Engineering a minimalistic allosteric system.
    Rabbani S; Fiege B; Eris D; Silbermann M; Jakob RP; Navarra G; Maier T; Ernst B
    J Biol Chem; 2018 Feb; 293(5):1835-1849. PubMed ID: 29180452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FimH forms catch bonds that are enhanced by mechanical force due to allosteric regulation.
    Yakovenko O; Sharma S; Forero M; Tchesnokova V; Aprikian P; Kidd B; Mach A; Vogel V; Sokurenko E; Thomas WE
    J Biol Chem; 2008 Apr; 283(17):11596-605. PubMed ID: 18292092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding site plasticity regulation of the FimH catch-bond mechanism.
    Languin-Cattoën O; Sterpone F; Stirnemann G
    Biophys J; 2023 Jul; 122(13):2744-2756. PubMed ID: 37264571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FimH and Anti-Adhesive Therapeutics: A Disarming Strategy Against Uropathogens.
    Sarshar M; Behzadi P; Ambrosi C; Zagaglia C; Palamara AT; Scribano D
    Antibiotics (Basel); 2020 Jul; 9(7):. PubMed ID: 32664222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, biological evaluation and docking study of some new aryl and heteroaryl thiomannosides as FimH antagonists.
    Mohammed AF; Othman SA; Abou-Ghadir OF; Kotb AA; Mostafa YA; El-Mokhtar MA; Abdu-Allah HHM
    Bioorg Chem; 2024 Apr; 145():107258. PubMed ID: 38447463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated shear stress protects Escherichia coli cells adhering to surfaces via catch bonds from detachment by soluble inhibitors.
    Nilsson LM; Thomas WE; Sokurenko EV; Vogel V
    Appl Environ Microbiol; 2006 Apr; 72(4):3005-10. PubMed ID: 16598008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. En route to photoaffinity labeling of the bacterial lectin FimH.
    Lindhorst TK; Märten M; Fuchs A; Knight SD
    Beilstein J Org Chem; 2010 Aug; 6():810-22. PubMed ID: 20978617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does size matter? - Comparing pyranoses with septanoses as ligands of the bacterial lectin FimH.
    Cramer J; Pero B; Jiang X; Bosko C; Silbermann M; Rabbani S; Wilke S; Nemli DD; Ernst B; Peczuh MW
    Eur J Med Chem; 2024 Mar; 268():116225. PubMed ID: 38367495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Orally Bioavailable FmlH Lectin Antagonists as Treatment for Urinary Tract Infections.
    Maddirala AR; Tamadonfar K; Pinkner JS; Sanick D; Hultgren SJ; Janetka JW
    J Med Chem; 2024 Mar; 67(5):3668-3678. PubMed ID: 38308631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycomimetics for the inhibition and modulation of lectins.
    Leusmann S; Ménová P; Shanin E; Titz A; Rademacher C
    Chem Soc Rev; 2023 Jun; 52(11):3663-3740. PubMed ID: 37232696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 1 piliated uropathogenic
    Tomasek K; Leithner A; Glatzova I; Lukesch MS; Guet CC; Sixt M
    Elife; 2022 Jul; 11():. PubMed ID: 35881547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which Properties Allow Ligands to Open and Bind to the Transient Binding Pocket of Human Aldose Reductase?
    Sandner A; Ngo K; Sager CP; Scheer F; Daude M; Diederich WE; Heine A; Klebe G
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing the enthalpic contribution of hydrogen bonds by solvent shielding.
    Cramer J; Jiang X; Schönemann W; Silbermann M; Zihlmann P; Siegrist S; Fiege B; Jakob RP; Rabbani S; Maier T; Ernst B
    RSC Chem Biol; 2020 Oct; 1(4):281-287. PubMed ID: 34458766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scaffold diversity for enhanced activity of glycosylated inhibitors of fungal adhesion.
    Martin H; Somers T; Dwyer M; Robson R; Pfeffer FM; Bjornsson R; Krämer T; Kavanagh K; Velasco-Torrijos T
    RSC Med Chem; 2020 Dec; 11(12):1386-1401. PubMed ID: 34095846
    [No Abstract]   [Full Text] [Related]  

  • 16. Developments in Mannose-Based Treatments for Uropathogenic Escherichia coli-Induced Urinary Tract Infections.
    Hatton NE; Baumann CG; Fascione MA
    Chembiochem; 2021 Feb; 22(4):613-629. PubMed ID: 32876368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Interaction of Fluorinated Glycomimetics with DC-SIGN: Multiple Binding Modes Disentangled by the Combination of NMR Methods and MD Simulations.
    Martínez JD; Infantino AS; Valverde P; Diercks T; Delgado S; Reichardt NC; Ardá A; Cañada FJ; Oscarson S; Jiménez-Barbero J
    Pharmaceuticals (Basel); 2020 Aug; 13(8):. PubMed ID: 32759765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Influence of Varying Fluorination Patterns on the Thermodynamics and Kinetics of Benzenesulfonamide Binding to Human Carbonic Anhydrase II.
    Glöckner S; Ngo K; Wagner B; Heine A; Klebe G
    Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32230853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary tract infections: microbial pathogenesis, host-pathogen interactions and new treatment strategies.
    Klein RD; Hultgren SJ
    Nat Rev Microbiol; 2020 Apr; 18(4):211-226. PubMed ID: 32071440
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.